<Disease><Name>PEROXISOME BIOGENESIS DISORDER 3B (PBD3B)</Name><Synonym>INFANTILE REFSUMS DISEASE</Synonym><OMIM><Number>266510</Number><URL>http://omim.org/entry/266510</URL></OMIM><Orphanet><Number>772</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=772</URL></Orphanet><Protein><Number>Peroxisome assembly protein 12</Number><URL>http://www.uniprot.org/uniprot/O00623</URL></Protein><ExPASy><Number /><URL /></ExPASy><Gene>17q12</Gene><ICD>G60.1</ICD><Summary>rare ;autosomal recessive;mutation in the PEX12 gene</Summary><Symptoms><symtomp><id>2209</id><symptom>anosmia</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>1932</id><symptom>defect of deep tendon reflexes</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2227</id><symptom>dysmorphism / dysmorphic features</symptom><category>HEAD</category></symtomp><symtomp><id>2160</id><symptom>EEG abnormalities [-]</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2095</id><symptom>failure to thrive</symptom><category>GASTROINTESTINAL SYSTEM | GENERAL TOPICS</category></symtomp><symtomp><id>1759</id><symptom>flat facies (Potter facies)</symptom><category>HEAD</category></symtomp><symtomp><id>1793</id><symptom>flattened nose</symptom><category>HEAD</category></symtomp><symtomp><id>2433</id><symptom>hearing defect, deafness</symptom><category>EARS | NERVOUS SYSTEM</category></symtomp><symtomp><id>1994</id><symptom>hepatomegaly (large liver)</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1897</id><symptom>hypotonia</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2213</id><symptom>MRI, brain, abnormalities [-]</symptom><category>LABORATORY FINDINGS | NERVOUS SYSTEM</category></symtomp><symtomp><id>1917</id><symptom>neurological deterioration / neurologic deterioration</symptom><category>GENERAL TOPICS | NERVOUS SYSTEM</category></symtomp><symtomp><id>2554</id><symptom>onset, fetus / fetal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2127</id><symptom>osteoporosis</symptom><category>SKELATAL DEFECT</category></symtomp><symtomp><id>1939</id><symptom>peripheral neuropathy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2490</id><symptom>Plasmalogens, biosynthesis</symptom><category>LABORATORY FINDINGS | LABORATORY FINDINGS</category></symtomp><symtomp><id>1731</id><symptom>retinitis pigmentosa</symptom><category>EYES</category></symtomp></Symptoms><Metabolites><metabolite><id>843</id><name>Alkyl-dihydroxyacetone-phosphate synthase</name><specimen>fibroblasts</specimen><value /><min>    </min><max>100.00</max><unit>% activity</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>437</id><name>C26:0</name><specimen>plasma</specimen><value>increased</value><min>0.45</min><max>1.32</max><unit>&#956;mol/l</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>786</id><name>C26:0</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.00</min><max>0.06</max><unit>&#956;g/ml</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>838</id><name>C26:0</name><specimen>fibroblasts</specimen><value>increased</value><min>0.05</min><max>0.21</max><unit>&#181;g/mg</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>840</id><name>Phytanic acid oxidation</name><specimen>fibroblasts</specimen><value>increased</value><min>5.30</min><max>18.80</max><unit>% oxidized</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>436</id><name>Phytanic acid</name><specimen>plasma</specimen><value>increased</value><min>0.00</min><max>3.10</max><unit>&#956;g/ml</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>500</id><name>Phytanic acid</name><specimen>plasma</specimen><value>increased</value><min>0.00</min><max>4.00</max><unit>&#956;g/ml</unit><age>child</age><method /><comment /></metabolite><metabolite><id>881</id><name>Phytanic acid</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.00</min><max>4.00</max><unit>&#956;g/l</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>433</id><name>Pipecolic acid</name><specimen>urine</specimen><value>increased</value><min>0.50</min><max>35.00</max><unit>mmol/mol creatinine</unit><age>infancy</age><method>GCMS</method><comment /></metabolite><metabolite><id>435</id><name>Pipecolic acid</name><specimen>urine</specimen><value>increased</value><min>0.10</min><max>3.50</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method>GCMS</method><comment /></metabolite><metabolite><id>2036</id><name>Pipecolic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>Bruker 2018</comment></metabolite><metabolite><id>428</id><name>Pipecolic acid</name><specimen>plasma</specimen><value>increased</value><min>0.80</min><max>5.30</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>429</id><name>Pipecolic acid</name><specimen>plasma</specimen><value>increased</value><min>0.50</min><max>3.80</max><unit>&#181;mol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>430</id><name>Pipecolic acid</name><specimen>plasma</specimen><value>increased</value><min>0.40</min><max>4.90</max><unit>&#181;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>431</id><name>Pipecolic acid</name><specimen>plasma</specimen><value>increased</value><min>0.70</min><max>2.60</max><unit>&#181;mol/l</unit><age>&gt;5 years</age><method /><comment /></metabolite><metabolite><id>432</id><name>Pipecolic acid</name><specimen>urine</specimen><value>increased</value><min>13.90</min><max>44.70</max><unit>&#181;mol/g creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>434</id><name>Pipecolic acid</name><specimen>urine</specimen><value>increased</value><min>1.60</min><max>13.40</max><unit>&#181;mol/g creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>842</id><name>Plasmalogens, biosynthesis</name><specimen>fibroblasts</specimen><value>increased</value><min>0.40</min><max>0.80</max><unit>3H/14C</unit><age>no data</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>2078</id><title>Infantile Refsum disease: serial evaluation with MRI</title><author>Cakirer S</author><journal>Pediatr Radiol</journal><year>2005</year><book /><volume>35</volume><number>2</number><pages>212-215</pages><co_aut>Savas MR</co_aut></literature><literature><id>4903</id><title>Novel mutations in the PEX12 gene of patients with a peroxisome biogenesis disorder</title><author>Gootjes J,</author><journal>Eur J Hum Genet. 2004 Feb;12(2):115-20.</journal><year>2004</year><book /><volume>12</volume><number>2</number><pages>115-120</pages><co_aut>et al.</co_aut></literature><literature><id>982</id><title>Plasma very long chain fatty acids in 3000 peroxisome disease patients and 29000 controls</title><author>Moser AB</author><journal>Ann Neurol</journal><year>1999</year><book /><volume>45</volume><number>1</number><pages>100-110</pages><co_aut>et al.</co_aut></literature><literature><id>116</id><title>Disorders of peroxisome biogenesis</title><author>Lazarow PB</author><journal>The metabolic and molecular bases of inherited disease, 7/e; Editors: C.R.Scriver, A.L.Beaudet, W.S.Sly, D.Valle; McGraw-Hill Inc.</journal><year>1995</year><book /><volume>2</volume><number>71</number><pages>2287-2324</pages><co_aut>Moser HW</co_aut></literature><literature><id>229</id><title>Peroxisomal disorders</title><author>Heymans HS</author><journal>J Inherit Metab Dis</journal><year>1995</year><book /><volume>0</volume><number>0</number><pages>421-433</pages><co_aut>Wanders RJA, Schutgens RBH</co_aut></literature><literature><id>232</id><title>Clinical approach to inherited peroxisomal disorders</title><author>Poggi-Travert F</author><journal>J Inher Met Dis Suppl</journal><year>1995</year><book /><volume>18</volume><number>0</number><pages>1-18</pages><co_aut>et al.</co_aut></literature><literature><id>6</id><title>Measurement of Plasma Very Long-Chain Fatty Acids as a Preliminary Screening Procedure for the Diagnosis of Peroxysomal Disorder</title><author>Steinberg SJ</author><journal>J Inher Metab Dis</journal><year>1994</year><book /><volume>17</volume><number>0</number><pages>323-326</pages><co_aut>Fensom AH, Dalton NR, Toseland PA, Kennedy CR, Mowat AP</co_aut></literature><literature><id>231</id><title>Clinical and biochemical characteristics of peroxisomal disorders: un update</title><author>Wanders RJA</author><journal>Eur J Pediatr Suppl</journal><year>1994</year><book /><volume>153</volume><number>0</number><pages>S44-S48</pages><co_aut>Barth PG, Schutgens RBH, Tager JM</co_aut></literature></Literatures></Disease>